BioPharma Dive October 29, 2025
Jonathan Gardner

The deal, which enables patients to pick up orders placed through Lilly’s online channel at Walmart pharmacies, is the latest move by the company to expand its direct-to-consumer services.

Dive Brief:

  • Eli Lilly is partnering with Walmart to help expand access to its obesity shot Zepbound, announcing Wednesday a deal that enables patients to pick up orders made through the drugmaker’s online service at the superstore chain’s pharmacies.
  • Retail pickup at Walmart will be available by mid-November for people with Zepbound prescriptions who pay cash instead of relying on insurance to cover the cost. Zepbound’s cost for people using this option is 50% lower than the list price of other GLP-1 obesity medications, Lilly said.
  • The Walmart partnership extends...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech, Provider, Retailer
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal

Share Article